Medifast, Inc. MED
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About MED
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
Medifast, Inc. is a U.S.-based health and wellness company focused on weight management, nutrition, and healthy lifestyle coaching. The company operates primarily through its OPTAVIA brand, which combines portion-controlled meal replacements, coaching support, and habit-based lifestyle programs designed to help consumers achieve weight loss and long-term weight management goals. Medifast operates within the broader nutrition, wellness, direct selling, and consumer health industries, with revenue generated mainly through sales of branded food products and associated coaching-driven programs.
The company’s primary revenue driver is the OPTAVIA direct-to-consumer model, where independent coaches support clients using structured nutrition plans and packaged products. Medifast historically evolved from a medically oriented meal replacement company founded in 1980 into a broader lifestyle and wellness platform emphasizing behavioral health and community-based coaching. Its strategic positioning centers on a scalable coach network, vertically integrated product development and distribution capabilities, and recurring customer engagement through subscription-like purchasing patterns.
Business Operations
Medifast conducts operations primarily through its OPTAVIA segment, which represents substantially all company revenue according to recent SEC filings. The company develops, manufactures, distributes, and markets branded meal replacements, snacks, beverages, and nutritional products. Revenue is generated through product sales to end consumers, primarily facilitated by a network of independent OPTAVIA coaches. The company maintains a vertically integrated operating structure that includes product formulation, supply chain oversight, marketing, digital infrastructure, and fulfillment operations.
The company’s operations are concentrated mainly in the United States, though it has expanded into selected international markets including Hong Kong and Singapore through the OPTAVIA platform. Medifast controls various proprietary nutrition formulations and digital coaching tools that support customer engagement and retention. The company also operates through subsidiaries associated with product manufacturing and distribution activities, including Jason Pharmaceuticals, Inc. Historically, Medifast maintained physician-supervised diet channels and franchise weight-control centers, though the direct-to-consumer coaching model has become the dominant operational focus in recent years.
Strategic Position & Investments
Medifast’s strategic direction has focused on expanding the OPTAVIA ecosystem through coach network growth, digital engagement, and broader wellness-oriented consumer offerings. The company has invested in technology infrastructure, personalized health platforms, and operational scalability intended to support customer acquisition and retention. Management has consistently emphasized long-term growth through lifestyle transformation programs rather than standalone diet products, positioning the business within the preventive wellness and behavioral health market.
The company has also pursued investments in manufacturing efficiency, supply chain resilience, and product innovation. While Medifast has not been as acquisition-focused as some larger consumer health peers, it has concentrated capital allocation on brand development, operational capacity, and shareholder returns through stock repurchases and dividends. Emerging areas of interest include digital health integration, data-enabled coaching support, and broader healthy aging and metabolic wellness categories. Public disclosures indicate that the company continues evaluating opportunities to diversify offerings while maintaining the coach-led direct selling structure central to the OPTAVIA brand.
Geographic Footprint
Medifast is headquartered in Baltimore, Maryland, and derives the substantial majority of its revenue from the United States market. The company’s distribution, fulfillment, and coach network are heavily concentrated across North America, where consumer awareness of the OPTAVIA brand is strongest. Its operational footprint includes manufacturing and logistics relationships that support nationwide direct-to-consumer delivery capabilities.
Internationally, Medifast has established a limited but notable presence in parts of Asia-Pacific, particularly Hong Kong and Singapore, where the company has introduced the OPTAVIA coaching and nutrition model. Compared with multinational nutrition conglomerates, Medifast’s international exposure remains relatively modest, though management has identified selective international expansion as a potential long-term opportunity. Publicly available filings indicate that the company continues prioritizing operational execution and market penetration in existing regions before pursuing broader global expansion.
Leadership & Governance
Medifast leadership has emphasized disciplined growth, operational efficiency, and the expansion of the coach-driven wellness model. Governance oversight is provided by the company’s board of directors and executive leadership team, with strategic priorities centered on sustainable customer acquisition, brand development, and shareholder value creation. The company’s leadership philosophy has consistently highlighted health transformation through coaching accountability, structured nutrition programs, and community engagement.
Key executives include:
- Dan Chard – Chief Executive Officer
- James P. Maloney – Chief Financial Officer
- Ryan Napierski – Former President and Chief Executive Officer
- Jennifer Christman – Chief Human Resources Officer
- Bonnie Fanelli – General Counsel and Corporate Secretary
Public company disclosures, including recent SEC filings, indicate that management remains focused on strengthening the OPTAVIA brand, supporting coach productivity, improving operational scalability, and navigating changing consumer demand trends within the health and wellness sector.